Tumor-induced inflammation

被引:0
|
作者
Madej, Janusz A. [1 ]
机构
[1] Uniwersytet Przyrodniczy Wroclawiu, Katedra Patol, Zaklad Patomorfol & Weterynarii Sadowej, Wydzial Med Weterynaryjnej, Ul Norwida 29, PL-50375 Wroclaw, Poland
来源
MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE | 2025年 / 81卷 / 01期
关键词
cancer-inducing inflammation; external and internal factors; range relations between cancer cells and inflammatory cells; NF-KAPPA-B; CANCER; IMMUNITY;
D O I
10.21521/mw.6931
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The role of inflammatory cells in the induction of various cancers was presented, with their division into: strong defenders of the body (T CD4+, T CD8+, Th1, Th2, NK, NKT, LAK, CKK, MAIT, T-cell CART), defenders or ,,collaborators" (B lymphocytes, M1 and M2 macrophages, N1 and N2 neutrophils) and enemies (MDSC, Th17). The described phenomena were correlated with three-stage tumor immunoediting. The range relations between cancer cells (A) and inflammatory cells (B) were presented graphically in the form of mathematical Euler circles in Figure 2, while external factors (A) and internal factors (B) involved in the induction of inflammatory infiltrate, which play an important role in cancer transformation, were illustrated using an adapted Venn diagram (10) in Figure 3. Although some anti-inflammatory drugs (aspirin, COX2) inhibit the risk of colorectal cancer in humans, there is still a long way to go to fully understand how cancer cells ,,manipulate" inflammatory cells for their growth and survival needs.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 50 条
  • [21] Tumor-induced hypoglycemia
    Le Roith, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10): : 757 - 758
  • [22] Tumor-induced immunosuppression
    Paul, S
    Calmels, B
    Régulier, E
    ANNALES DE BIOLOGIE CLINIQUE, 2002, 60 (02) : 143 - 152
  • [23] Tumor-induced osteomalacia
    Chong, William H.
    Molinolo, Alfredo A.
    Chen, Clara C.
    Collins, Michael T.
    ENDOCRINE-RELATED CANCER, 2011, 18 (03) : R53 - R77
  • [24] TUMOR-INDUCED IMMUNOSUPPRESSION
    FRIEDMAN, H
    SPECTER, S
    WATANABE, M
    PAN, SH
    AMERICAN JOURNAL OF PATHOLOGY, 1978, 93 (02): : 499 - 513
  • [25] Tumor-induced osteomalacia
    Annamalai, Anand K.
    Shinto, Ajit
    Aram, Subramanian
    Prabhu, Veeranathevar Ananji
    Santhi, Radhakrishnan
    Gopalakrishnan, Chandrasekaran
    Chelian, Mathirajan
    Srinivasan, Kaliappan Gurusamy
    KIDNEY INTERNATIONAL, 2022, 102 (05) : 1194 - 1194
  • [26] Tumor-induced osteomalacia
    Mala Kaul
    Miriam Silverberg
    Edward F. DiCarlo
    Robert Schneider
    Anne R. Bass
    Doruk Erkan
    Clinical Rheumatology, 2007, 26 : 1575 - 1579
  • [27] TUMOR-INDUCED OSTEOMALACIA
    IOAKIMIDIS, DE
    DENDRINOS, GK
    FRANGIA, KB
    BABIOLAKIS, DN
    CHILAS, GI
    LYBEROPOULOS, KL
    KONTOMERKOS, TK
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (06) : 1162 - 1164
  • [28] TUMOR-INDUCED OSTEOMALACIA
    Mastaglia, Silvina
    Somoza, Julia
    Gonzalez, Diana
    Oliveri, Beatriz
    ACTUALIZACIONES EN OSTEOLOGIA, 2013, 9 (02) : 194 - 202
  • [29] Tumor-induced osteomalacia
    Vollbrecht, Jill E.
    Rao, D. Sudhaker
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12): : 1282 - 1282
  • [30] Therapeutic intervention sites for resveratrol in the prometastatic microenvironment of tumor-induced hepatic inflammation
    Salado, Clarisa
    Gallot, Natalia
    Mendoza, Lorea
    Egilegor, Eider
    Vidal-Vanaclocha, Fernando
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3547S - 3547S